Scott Kellen
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | DiaMedica Therapeutics Inc. (DMAC) | Chief Financial Officer and Secretary | $408,500 | $1,229,520 |
| 2024 | DiaMedica Therapeutics Inc. (DMAC) | Chief Financial Officer and Secretary | $374,250 | $813,955 |
| 2023 | DiaMedica Therapeutics Inc. (DMAC) | Chief Financial Officer and Secretary | $352,750 | $632,215 |
| 2022 | DiaMedica Therapeutics Inc. (DMAC) | Chief Financial Officer and Secretary | $329,392 | $563,574 |
| 2021 | DiaMedica Therapeutics Inc. (DMAC) | Chief Financial Officer and Secretary | $286,211 | $546,720 |
| 2020 | DiaMedica Therapeutics Inc. (DMAC) | Chief Financial Officer and Secretary | $276,075 | $489,303 |
| 2019 | DiaMedica Therapeutics Inc. (DMAC) | Chief Financial Officer and Secretary | $262,500 | $677,807 |
| 2018 | DiaMedica Therapeutics Inc. (DMAC) | Chief Financial Officer and Secretary | $200,833 | $642,921 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.